名称 | 銘柄コード | 市場 | 種別 |
---|---|---|---|
NKGen Biotech Inc | NKGN | NASDAQ | 普通株式 |
始値 | 安値 | 高値 | 終値 | 前日終値 |
---|---|---|---|---|
1.42 | 1.25 | 2.14 | 1.71 | 1.12 |
最新ニュース
日付 | 時間 | ソース | タイトル |
---|---|---|---|
2024/2/23 | 06:01 | EDGAR2 | Form 8-K - Current report |
2024/2/15 | 10:19 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2024/2/15 | 10:16 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2024/2/15 | 10:14 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2024/2/15 | 10:11 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2024/2/15 | 03:05 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
2024/1/22 | 20:12 | EDGAR2 | Form 8-K - Current report |
2024/1/09 | 07:19 | EDGAR2 | Form 8-K - Current report |
2023/12/29 | 06:14 | EDGAR2 | Form 8-K - Current report |
2023/12/28 | 06:02 | EDGAR2 | Form 8-K - Current report |
2023/12/28 | 06:01 | EDGAR2 | Form 8-K - Current report |
2023/12/20 | 03:41 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
2023/11/15 | 06:39 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
2023/10/24 | 23:56 | DJN | NKGen Biotech Shares Rise 8% After FDA Clears IND.. |
2023/10/24 | 21:05 | EDGAR2 | Form 8-K - Current report |